Krystal Biotech (KRYS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Discover why NNNN's pivot to oncology and other assays faces challenges as COVID-related revenues decline, with valuation ...

Trump’s tariffs and the trade war continue to affect global markets. Follow along for live updates on the Dow, S&P 500 and Nasdaq.

MAIA’s Chairman and CEO Vlad Vitoc, M.D., expressed optimism regarding the results, stating, "This new benchmark of 17.8 months median OS is nearly triple the recognized SOC data for third-line NSCLC ...

Boosted by strong demand, Rhythm Pharmaceuticals joins the ranks of biotech stocks to watch looking to engineer a breakout.

For all the attention on U.S.-China AI competition, new studies point to China’s rapid rise in biotechnology, especially for drug and agricultural development.

Later this month, the Food and Drug Administration is widely expected to approve a groundbreaking twice-yearly injection to ...

Any point can be considered low -- even after massive gains -- provided there is plenty of upside left. That brings us to ...

Cibus, Inc. (Nasdaq: CBUS) (the “Company” or “Cibus”), a leading agricultural biotechnology company that uses proprietary gene editing technologies to develop plant ...

Relative to drug developers, medical device makers have outperformed amid the turmoil of the Trump administration's healthcare reforms.

Regencell's stock soared 17,000% fueled by speculation, despite no revenue or clinical progress. Read why I think the RGC ...

Merck submitted a nonbinding offer for the smaller biotech earlier in the year, according to a media report citing people ...